It's being led by Vic Gundotra, a former Google executive.Īnd Apple is eyeing the space too, with several software frameworks, such as ResearchKit, targeted directly at clinical researchers. Startup AliveCor currently sells a portable ECG sensor that pairs with an iPhone app and has developed an Apple Watch ECG band that's currently awaiting regulatory approval. Lots of competitionĪlphabet, Verily's parent company, is not the only tech company looking to gain a foothold in the competitive healthcare business. Verily is pitching medical researchers on services that combine hardware and big data analysis to supercharge clinical studies. It sounds like they're geared towards medical researchers, for use in studies like Verily's Baseline study. Other smartwatches, like Apple's, can't do that yet.īut don't expect to walk into a Best Buy and purchase one of these smartwatches anytime soon. One sensor measures an ECG, which is the electrical rhythm of the heart. The device is packed with medical sensors for collecting data on what's going on in the body. “The big push now is low-power," Otis told the Technology Review. They can display color, but use a lot more power than E-Ink. Other smartwatches, including the Apple Watch and most running Google's Android Wear software, use LCD or OLED screens. The company is also designing its own chips to keep power usage down. The watch won't need to be charged every day, says Brian Otis, CTO of Verily. The smartwatch is equipped with a digital watch face and a circular e-ink display, according to Antonio Regalado, writing for MIT Tech Review, who inspected the watch during an interview. It often indicates a user profile.Īlphabet's life sciences spin-off, Verily, is working on a health-tracking smartwatch and has built "hundreds" of prototypes. Account icon An icon in the shape of a person's head and shoulders.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |